Switch to Dark

Pricing

Learn

BMY - Bristol-Myers Squibb Co

301

$59.29

-$0.42 (-0.703%)

3/18/26, 5:15 PM

Score

3.86/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Income Statement Summary

Metrics

KPIs

View as %

Bristol-Myers Squibb Co

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Total Revenue	15.7%	11.62%	$12.05B	$12.25B	$11.20B 2025-03-31	$12.50B 2025-12-31	$12.50B 2025-12-31

Operating Expenses	22.43%	16.47%	$4.43B	$4.41B	$4.12B 2025-03-31	$4.80B 2025-12-31	$4.80B 2025-12-31

Net Interest Income Expense	--	78.34%	-$256.25M	-$248.50M	-$434.00M 2025-03-31	-$94.00M 2025-12-31	-$94.00M 2025-12-31

Income Tax Expense	-31.2%	-24.56%	$568.00M	$484.50M	$384.00M 2025-12-31	$919.00M 2025-09-30	$384.00M 2025-12-31

Cost of Goods Sold (COGS)	22.06%	16.2%	$3.30B	$3.33B	$3.02B 2025-03-31	$3.51B 2025-12-31	$3.51B 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Total Revenue	12,502,000	12,222,000	12,269,000	11,201,000	42,069,000	8148642	9508913	4329306	5263866	7565229	9141975	4932145	4644606	8688285	8901848	649831	3434750	9694238
Cost of Goods Sold (COGS)	3,507,000	3,312,000	3,356,000	3,018,000	42,069,000	2822916	3438292	3244599	6252386	988651	6493830	3604285	2238201	1146752	8053861	1095586	8017248	3658969
Gross Profit	8,995,000	8,910,000	8,913,000	8,183,000	42,069,000	7288251	6773769	8689623	6846671	1643247	1491535	7763517	2335678	2425708	5369537	3195490	2794580	352301
Operating Expenses	4,795,000	4,491,000	4,334,000	4,117,000	42,069,000	910341	102629	7373457	9405825	5620013	3515486	8353236	6617385	1373845	761293	4324620	2162303	8664330
Research & Development	2,561,000	2,433,000	2,262,000	2,236,000	42,069,000	4782029	141103	591817	937860	133309	7031535	4358046	2667503	6683552	1756048	7701018	9848946	5595625
Selling, General & Administrative Expenses	2,088,000	1,788,000	1,691,000	1,583,000	42,069,000	5248049	825397	3828096	3393970	5014688	8091763	1639573	452803	6308364	8500870	71884	7687491	7297764
Operating Income or Loss	4,200,000	4,419,000	4,579,000	4,066,000	42,069,000	3287700	3546304	3939754	33153	1285095	3533849	7480053	5250134	1321099	7761491	9067659	8995293	8747733
Interest Expense	-432,000	-480,000	-485,000	-494,000	42,069,000	1851316	4192737	116825	6842291	6346276	1405465	7297175	8414800	4873691	5619621	6609489	6193187	4930782
Net Interest Income Expense	-94,000	-129,000	-368,000	-434,000	42,069,000	8202270	9323842	3131039	9974188	4236927	5860646	9789610	4306102	726090	6320488	963699	3494617	3474296
Non-Recurring Items	-2,654,000	-1,128,000	-2,459,000	-658,000	42,069,000	2740471	1273015	8619045	4119733	7696445	2941620	1328374	5054758	2428903	7322525	9758224	379519	6328153
Total Other Income/Expense Net	18,000	-48,000	21,000	-3,000	42,069,000	2623653	5164472	6595143	7403701	4823281	4922501	1088476	1936973	9091970	669184	9402200	2385909	2808518
Income Before Tax	1,470,000	3,114,000	1,773,000	2,971,000	42,069,000	7440529	1986392	8922677	8033897	5023303	9909917	2626104	7251527	3711231	5712665	1802621	4977061	9777797
Income Tax Expense	384,000	919,000	460,000	509,000	42,069,000	4114314	9877039	6326705	4162936	8202236	1928974	428927	4912909	4684088	4115127	3360022	9724298	8583939
Earnings	1,087,000	2,201,000	1,310,000	2,456,000	42,069,000	2964077	1322452	6466567	9528536	4878456	6550829	9678244	8081659	8086160	7271928	7669096	164558	2893930
Adjusted Net Income	-1,567,000	1,073,000	-1,149,000	1,798,000	42,069,000	3078009	9681536	9851940	5740043	3058321	9182964	5446589	8464634	607409	569550	3568685	2366475	7193845
Net Income After Taxes	1,086,000	2,195,000	1,313,000	2,462,000	42,069,000	4531801	8239186	5696653	570526	203135	3950515	8993955	3138372	8938710	1188952	6485942	8558586	9776893
Diluted Shares Outstanding	2,039,000	2,039,000	2,038,000	2,040,000	42,069	7480342	1724619	1013158	3476698	2246593	2947053	2532308	7414658	3040152	1002617	13939	6265803	1875305
Diluted EPS	0.53	1.08	0.64	1.2	42,069	7498011	5749868	2038192	228202	8414013	6466877	2382486	2116216	9024077	9565473	9962661	7427830	146838
Adjusted EPS	-0.77	0.53	-0.56	0.88	42,069	6835261	9007396	684242	1440402	9517871	6129322	1132852	22739	8257561	1609913	5322030	8441702	7784498
EBITDA	5,177,000	5,430,000	5,590,000	5,078,000	42,069,000	601320	2439334	8343723	178483	6157253	4533515	7431798	4492099	4623099	6190793	4536086	3583847	5947999